The Quick Extender Pro is effective in correcting penile curvature. Whether you are suffering from peyronie’s disease or if you would like to correct an unattractive curved penis, the Quick Extender Pro will act as a penis brace, similar to how dental braces are used to straighten crooked teeth.
Contents
How Does The Quick Extender Pro Correct Penile Curvature?
The Quick Extender Pro will correct the curvature by applying Newton’s laws of physics; every action has an equal and opposite reaction.
The opposing force applied by the device to your penis will gradually reverse the curvature until it becomes straight.
Recent studies conducted through global surveys have demonstrated that women consider a curved penis to be less attractive both aesthetically and sexually. The findings reveal that along with the unattractive aspects of a curved penis, sexual intercourse becomes less pleasurable for both partners and sometimes results in a painful experience.
Women who’ve experienced sexual intercourse with men possessing a curved penis have reported difficulties making contact with the g spot (Ernst Gräfenberg 1950) which lowered their chances even further of achieving orgasm. A straight penis is ideal for penetration. A woman’s G spot consists of a small patch inside the vagina and can easily be missed by the slightest curve of your penis.
With the introduction of modern penile traction systems, correcting penile curvature is now possible without surgical intervention for as low as $179.93 with the Quick Extender Pro Curvature Correction Edition extender.
Peyronie’s Disease Information
Peyronie’s disease is a tissue disorder involving the growth of fibrous plaques in the soft tissue of the penis. This condition is believed to affect as many as 2-3% of men but recent research shows that the numbers may be higher.
There are different degrees of Peyronie’s disease. More severe cases may cause pain, hardened, cord-like lesions (scar tissue known as “plaques”) or an abnormal curvature of the penis when erect. In addition, narrowing and or shortening of the penis may occur.
Erectile dysfunction, in varying degrees, often accompanies these symptoms in the later stages of the disease. The condition may also make sexual intercourse painful and difficult. Although it can affect men of any race and age, it is most commonly seen in Caucasian males above the age of 25.
Peyronie’s Disease is not contagious, nor is it related in any way to cancer. The disease only affects men and is confined to the penis, although a substantial number of men with Peyronie’s exhibit concurrent connective tissue disorders in the hand, and to a lesser degree, in the feet.
Peyronie’s Disease can be a physically and psychologically devastating condition. While most men will continue to be able to have sexual relations, they are likely to experience some degree of deformity and erectile dysfunction in the wake of the disease. It is not uncommon for men afflicted with Peyronie’s Disease to exhibit depression, withdrawal from their sexual partners and unwillingness to talk openly about their concerns with their partner and or physician. Treatment is readily available through third party vendors.
Please note
The Quick Extender Pro is designed to correct the curvature and aesthetic aspects accompanied by this condition. The specially calibrated tension springs are designed to provide the correct amount of pressure to correct the penile curvature left behind by Peyronie’s disease.
You must follow your doctors instructions and continue using any medication prescribed as a Peyronie’s disease treatment.
References and Scientific Literature
Peyronie’s Disease Knowledge And Practice Patterns Assessment: A Survey Of Urologists In The United State Article Date: 02 July 2008 – 5:00 PDT
Urologist practice patterns in the management of Peyronie’s disease: a nationwide survey. Washington University in Saint Louis-Department of Surgery, Division of Urology, St. Louis, MO, USA. shindela@urology.ucsf.edu “The journal of sexual medicine.”J Sex Med. 2008 Apr;5(4):954-64. Epub 2007 Nov 27
The prevalence of Peyronie’s disease : results of a large survey SCHWARZER U. (1) ; SOMMER F. (1) ; KLOTZ T. (1) ; BRAUN M. (1) ; REIFENRATH B. (1) ; ENGELMANN U. (1) ; (1) Department of Urology, University of Cologne, Cologne, ALLEMAGNE BJU international ISSN 1464-4096 2001, vol. 88, no7, pp. 727-730 (26 ref.)
A Survey of Primary-Care Physicians and Urologists Regarding Peyronie’s Disease Jeffrey C. LaRochelle, MD, and Laurence A. Levine, MD Department of Urology, Rush University Medical Center, Chicago, IL, USA
U. Schwarzer , F. Sommer , T. Klotz , M. Braun , B. Reifenrath and U. Engelmann Department of Urology, University of Cologne, Cologne, Germany F. Sommer, Department of Urology, University of Cologne, Joseph‐Stelzmann‐Strasse 9, 50924 Koeln, Germany 10.1046/j.1464-4096.2001.02436.x
Urologist Practice Patterns in the Management of Peyronie’s Disease: A Nationwide Survey – Abstract Wednesday, 02 January 2008 Washington University in Saint Louis—Department of Surgery, Division of Urology, St. Louis, MO, USA
Epidemiology of Peyronie’s disease F Sommer1, U Schwarzer1, G Wassmer2, W Bloch3, M Braun1, T Klotz1 and U Engelmann1 International Journal of Impotence Research (2002) 14, 379-383. doi:10.1038/sj.ijir.3900863
Weidner W, Schroeder-Printzen, I., Weiske, W., Vosshenrich, R.: Sexual Dysfunction in Peyronie’s disease : An analysis of 222 patients without previous local plaque therapy. Journal of Urology 157: 325-328, 1997
de Meyer JJ et al. The effect of re-dosing of vasodilators on the intracavernosal pressure and on the penile rigidity. European Urology 33: 293-6, 1998
Rosen RC, Cappelleri JC, Smith MD, Lipsky J Pena BM: Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. International Journal of Impotence Research. 11: 319-26., 1999
Combination of Doxazosin and Sildenafil Exerts an Additive Relaxing Effect Compared with Each Compound Alone on Human Cavernosal and Prostatic Tissue Stéphanie Oger, PhD,* Delphine Behr-Roussel, PharmD, PhD,* Diane Gorny, RT,* Olivier Lecoz, RT,* Thierry Lebret, MD, † Yves Denoux, MD, † Antoine Faix, MD, ‡ Albert Leriche, MD, § Chris Wayman, PhD, Laurent Alexandre, MD,* and François Giuliano, MD, PhD
Müller A, and Mulhall JP. Peyronie’s disease intervention trials: Methodological challenges and issues. J Sex Med 2009;6:848–861
Gonzalez-Cadavid NF, and Rajfer J. Experimental models of peyronie’s disease. Implications for new therapies. J Sex Med 2009;6:303–313
Stereological and biochemical analysis of muscular and connective tissue components in the penile corpus cavernosum adjacent to the fibrous plaque of Peyronie’s disease Waldemar S. Costa, Sabrina B. Rebello, Luiz E.M. Cardoso, Andre G. Cavalcanti and Francisco J.B. Sampaio BJU International Volume 103 Issue 2, Pages 212 – 216
Smith JF, Walsh TJ, Conti SL, Turek P, and Lue T. Risk factors for emotional and relationship problems in Peyronie’s disease. J Sex Med 2008;5:2179–2184
Gontero P, Di Marco M, Giubilei G, Bartoletti R, Pappagallo G, Tizzani A, and Mondaini N. Use of penile extender device in the treatment of penile curvature as a result of Peyronie’s disease. Results of a phase II prospective study. J Sex Med 2009;6:558–566
